Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Geburtshilfe und Frauenheilkunde (2021) 81:469-480. https://doi.org/10.1055/a-1397-7170
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2024
- Urheber
-
Lux, Michael Patrick
Schneeweiss, Andreas
Hartkopf, Andreas
Müller, Volkmar
Janni, Wolfgang
Belleville, Erik
Stickeler, Elmar
Thill, Marc
Fasching, Peter Andreas
Kolberg, Hans-Christian
Untch, Michael
Harbeck, Nadia
Wöckel, Achim
Thomssen, Christoph
Schulmeyer, Carla E.
Welslau, Manfred
Overkamp, Friedrich
Schütz, Florian
Lüftner, Diana
Ditsch, Nina
- DOI
-
10.1055/a-1397-7170
- URN
-
urn:nbn:de:bvb:20-opus-369989
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:43 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lux, Michael Patrick
- Schneeweiss, Andreas
- Hartkopf, Andreas
- Müller, Volkmar
- Janni, Wolfgang
- Belleville, Erik
- Stickeler, Elmar
- Thill, Marc
- Fasching, Peter Andreas
- Kolberg, Hans-Christian
- Untch, Michael
- Harbeck, Nadia
- Wöckel, Achim
- Thomssen, Christoph
- Schulmeyer, Carla E.
- Welslau, Manfred
- Overkamp, Friedrich
- Schütz, Florian
- Lüftner, Diana
- Ditsch, Nina
- Universität Würzburg
Entstanden
- 2024
Ähnliche Objekte (12)
Breast cancer nab-Paclitaxel
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients
Immunotherapy: new options in breast cancer treatment
miR-183-5p|+2 suppresses cell cycle by targeting E2F1 in Triple Negative Breast Cancer
Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
Update breast cancer 2021 part 5 – advanced breast cancer
Update breast cancer 2022 part 1 : early stage breast cancer
Update breast cancer 2022 part 1 – early stage breast cancer
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice
Anomalien der Wirbelsäule beim Turner-Syndrom
Breast cancer nab-Paclitaxel
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients
Immunotherapy: new options in breast cancer treatment
miR-183-5p|+2 suppresses cell cycle by targeting E2F1 in Triple Negative Breast Cancer
Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
Update breast cancer 2021 part 5 – advanced breast cancer
Update breast cancer 2022 part 1 : early stage breast cancer
Update breast cancer 2022 part 1 – early stage breast cancer
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice
Anomalien der Wirbelsäule beim Turner-Syndrom
Breast cancer nab-Paclitaxel
Update Breast Cancer 2020 Part 5 – Moving Therapies From Advanced to Early Breast Cancer Patients
Update breast cancer 2020 part 5: moving therapies from advanced to early breast cancer patients
Immunotherapy: new options in breast cancer treatment
miR-183-5p|+2 suppresses cell cycle by targeting E2F1 in Triple Negative Breast Cancer
Update Breast Cancer 2021 Part 5 – Advanced Breast Cancer
Update breast cancer 2021 part 5 – advanced breast cancer
Update breast cancer 2022 part 1 : early stage breast cancer
Update breast cancer 2022 part 1 – early stage breast cancer
HER2 Dimerization Inhibitor Pertuzumab – Mode of Action and Clinical Data in Breast Cancer
Update breast cancer 2019 part 2 – implementation of novel diagnostics and therapeutics in advanced breast cancer patients in clinical practice